Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes
Authors:
- Elad ShemeshESElad Shemesh
- Keona PangKPKeona Pang
- Pascal B. MeyrePMPascal B. Meyre
- Alice ManAMAlice Man
- Josef GrafJGJosef Graf
- Shuang WangSWShuang Wang
- YanRan LiYLYanRan Li
- Pierre BeaucagePBPierre Beaucage
- Guilherme Luiz Da RochaGRGuilherme Luiz Da Rocha
- Michael KamalMKMichael Kamal
- Marie PigeyreMPMarie Pigeyre
- Michael D. ShapiroMSMichael D. Shapiro
- 5 November 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Genomic and Precision Medicine
Abstract
BACKGROUND: Risk at high-density lipoprotein cholesterol (HDL-C) extremes may reflect genetic predisposition, ancestry, or region, but their relative contributions remain unknown. We characterized extreme HDL-C associations with atherosclerotic cardiovascular disease and mortality, and examined whether genetic-phenotypic discordance identifies risk beyond measured HDL-C. METHODS: Atherosclerotic cardiovascular disease–free participants from UKB (UK Biobank) and All of Us (AoU) with extremely low (2.3 mmol/L; based on standard clinical guidelines) HDL-C were analyzed. A 247-variant polygenic score stratified European ancestry participants at each HDL-C extreme into tertiles; discordant groups had measured HDL-C contradicting genetic predisposition. RESULTS: Among 408 353 UKB and 115 423 AoU participants, extremely low HDL-C was associated with higher atherosclerotic cardiovascular disease (UKB: hazard ratio [HR], 1.33 [95% CI, 1.27–1.39]; AoU: HR, 1.32 [95% CI, 1.08–1.61]) and mortality (UKB: HR, 1.25 [95% CI, 1.20–1.30]; AoU: HR, 1.64 [95% CI, 1.37–1.96]) across ancestries. Extremely high HDL-C was associated with excess mortality in UKB European ancestry (HR, 1.28 [95% CI, 1.19–1.38]), driven by COPD (HR, 2.64 [1.94–3.59]) and lung infections (HR, 2.24 [95% CI, 1.48–3.39]), but not in AoU European ancestry. In UKB, this was confined to genetically discordant high HDL (high-density lipoprotein; polygenic score HDL T1; HR, 1.53 [95% CI, 1.22–1.92]); genetically concordant high HDL showed progressively lower mortality. Genetically discordant low HDL (polygenic score HDL T3) carried higher atherosclerotic cardiovascular disease (UKB: HR, 1.20 [95% CI, 1.08–1.34]; AoU: HR, 1.44 [95% CI, 1.15–1.81]) and mortality (UKB: HR, 1.22 [95% CI, 1.11–1.34]; AoU: HR, 1.75 [95% CI, 1.21–2.54]) than concordant low HDL (polygenic score HDL T1), comparable in magnitude to a 10 mm Hg increment in systolic blood pressure. CONCLUSIONS: Extreme HDL-C levels carry different cardiovascular and mortality risk depending on whether they reflect or contradict genetic predisposition, with additional variation by ancestry and region.Keywords
This publication has 29 references indexed in Scilit:
- Performance of the American Heart Association’s PREVENT Equations Among Disaggregated Racial and Ethnic SubgroupsJAMA Cardiology, 2025
- Race-Dependent Association of High-Density Lipoprotein Cholesterol Levels With Incident Coronary Artery DiseaseJACC, 2022
- Exome-wide association study of plasma lipids in >300,000 individualsNature Genetics, 2017
- HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammationNature, 2015
- The impact of low-frequency and rare variants on lipid levelsNature Genetics, 2015
- Discovery and refinement of loci associated with lipid levelsNature Genetics, 2013
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterolThe Journal of Heart and Lung Transplantation, 2011
- Lipid Profile, Plasma Apolipoproteins, and Risk of a First Myocardial Infarction Among AsiansJACC, 2009
- Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other CountriesJAMA, 2007